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cGMP signaling pathways. However, the role of PDE2 in the failing heart is only poorly 
understood. The aim of the present study was to investigate whether myocardial PDE2 is 
altered in human and experimental heart failure (HF) and to determine PDE2 mediated 
effects on β-adrenoceptor (β-AR) signaling in cardiomyocytes.
Methods and Results: Immunoblotting revealed that myocardial PDE2 expression 
was ~2-fold higher in advanced human and experimental HF but unchanged in 
hypertrophied hearts from patients with preserved cardiac function. Chronic β-AR 
stimulation via catecholamine infusions in rats (isoprenaline; 2.4 μg/g/d for 4 days) 
enhanced PDE2 expression ~2-fold and cAMP hydrolytic activity ~4-fold (measured by 
radioenzymatic assay and FRET-based sensors in the presence and absence of the specifi c 
PDE2 inhibitor BAY 60-7550), which correlated with blunted β -AR responsiveness. 
Consistently, adenovirus overexpressed PDE2, which was localized to the sarcomeric 
Z-line, reduced the rise in cAMP levels and the whole-cell L-type Ca2+ channel current 
(ICa,L) amplitude and abolished the positive inotropic effect following acute β-AR 
stimulation in cardiomyocytes. Importantly, all effects were reversible upon specifi c 
PDE2 inhibition with BAY 60-7550. Notably, PDE2 overexpressing cardiomyocytes 
also showed marked protection from norepinephrine-induced hypertrophic responses, 
e.g. 40% less increase in cell surface area.
Conclusions: PDE2 is markedly upregulated in failing hearts and desensitizes 
against acute β-AR stimulation. This may constitute an important defence mechanism 
during cardiac stress, e.g. by antagonizing excessive β-AR drive. Thus, activating 
myocardial PDE2 may represent a novel intracellular anti-adrenergic therapeutic 
strategy in HF.
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Introduction: Induced capillary leakage contributes to organ dysfunction during 
sepsis. However, the contribution of cardiac oedema to sepsis-induced left ventricular 
dysfunction remains to be clarifi ed. In addition, signalling pathways controlling the 
sepsis-induced myocardial oedema has not been identifi ed. We postulated that AMPK 
infl uenced vascular permeability during sepsis even in the heart and could modulate 
heart function during severe sepsis.
Methods and Results: Sepsis was triggered by LPS, 10 mg.kg-1 injection inducing 
systolic left ventricular dysfunction. Wild-type (WT) mice were compared to α1-AMPK 
knock-out (α1KO). In vivo vascular permeability was evaluated by dye extravasation. 
Left ventricular mass, oedema and function were studied by echocardiography and 
magnetic resonance imaging (MRI). Lung neutrophil deposition and myeloperoxydase 
activity were quantifi ed. Plasmatic cytokines were measured by cytometric bead array. 
LPS resulted in an increased systemic infl ammation. No difference was observed 
between WT and α1KO: acute lung injury as well as cytokines level after LPS did no 
differ between WT and α1KO. By contrast, α1KO exhibited a dramatic increased in 
the LPS-induced vascular hyperpermeability in the heart. Echocardiography revealed 
an increase in LV mass 24h after LPS in α1KO. MRI defi nitely demonstrated that 
increased LV mass corresponded to exaggerated LV wall oedema. This led to a 
decrease in end-diastolic volume. Despite more pronounced wall oedema in α1KO, 
no difference in systolic function could be detected between WT and α1KO after LPS. 
Conclusions: We demonstrate, for the fi rst time the involvement of a signalling 
pathway in the control of LV wall oedema during sepsis. AMPK exerts a protective 
action against myocardial oedema induced by LPS. Interestingly, exaggerated LV 
wall oedema is not associated with aggravated systolic dysfunction. However, it could 
contribute to diastolic dysfunction observed in septic patients. 
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Antibodies against the second extracellular loop of β1-adrenergic receptor 
induce endothelial dysfunction in aortic and mesenteric arteries of Wistar rat
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The presence of autoantibodies (AABs) against β1-adrenoceptors (β1-ARs) 
has been detected in sera of patients with cardiomyopathies. Such sustained β1-AR 
activation due to stimulatory β1-AABs, might have harmful infl uence on cardiac 
pathogenesis. However, the cardiac performance is also dependent on the interaction 
between the left ventricle and the arterial system and any increase of the post-load 
would participate in cardiac failure. Substantial hemodynamic improvements were 
found during immunoadsorption, but up to now the pathogenic action of β1-AABs has 
only been evaluated in heart. The purpose of the present study was to evaluate whether 
active immunization producing β1-AABs, has deleterious effects on vascular reactivity 
in rats. Enzyme-linked immunosorbent assay was used to detect β1-AABs in sera from 
immunized rats for 3 months with the peptidic sequence of the 2nd extracellular loop of 
the human β1-AR. Functional studies were performed in thoracic aortic (TA) and small 
mesenteric artery (SMA) rings from control (adjuvant-treated) and immunized rats. 
Following pre-contraction with phenylephrine, cumulative concentration-response curves 
(CCRCs) to various β-AR agonists, acetylcholine, A23187 and sodium nitroprusside 
(SNP) were then constructed. The relaxations induced by dobutamine, SR 58611A and 
acetylcholine (Ach) were signifi cantly impaired, but salbutamol-induced relaxations 
were not affected, in both vessels from immunized rats. A signifi cant impairment of 
isoproterenol-induced relaxations was only observed in SMA. CCRCs to SNP were not 
modifi ed in both vessels. A23187-induced relaxation was impaired in immunized rats. 
Following a pretreatment with L-arginine, vasorelaxations to Ach and SR 58611A were 
restored in immunized rats. The present study demonstrates that immunization against 
the 2nd extracellular loop of β1-ARs has deleterious impact on vasorelaxations in TA and 
SMA of rats, involving alterations of endothelium-dependent NO signalling pathway.
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Purpose: Diminished cAMP- and augmented cGMP-signaling is characteristic 
for failing hearts. Cyclic nucleotide phosphodiesterases (PDEs) comprise a family of 
cyclic-nucleotide hydrolysing enzymes, controlling cAMP and cGMP levels. Among 
them, the PDE2 isoform is a dual specifi city enzyme hydrolyzing both cAMP and 
cGMP. PDE2 is unique in being allosterically activated by cGMP, resulting in enhanced 
cAMP hydrolysis. This appears to mediate a negative cross-talk between cAMP- and 
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Involvement of CD73, ENT transporters and inosine in rhythm and conduction 
disturbances mediated by adenosine A1 and A2A receptors through ERK2 
activation in the developing heart
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We previously established that exogenous adenosine (ADO) induces transient 
arrhythmias in the developing heart via the adenosine A1 receptor (A1AR) and 
downstream activation of NADPH oxidase/ERK and PLC/PKC pathways. Here, we 
assessed the hypothesis that both endogenous ADO and its derived compound inosine 
(INO) can simultaneously act in an autocrine/paracrine manner and induce rhythm and 
conduction troubles. The validated model of the spontaneously beating heart obtained 
from 4-day-old chick embryos was used. Quantitative RT-PCR showed that enzymes 
involved in ADO and INO metabolism (CD39, CD73 and eADA), Equilibrative (ENT1, 
-3, -4) and Concentrative (CNT3) Nucleoside Transporters were differentially expressed 
in atria, ventricle and outfl ow tract. Inactivation of ENTs by dipyridamole (Dipy), 1) 
increased myocardial ADO level, 2) provoked atrial arrhythmias and atrio-ventricular 
blocks (AVB) in 70% of the hearts, 3) prolonged P wave and QT interval without 
altering contractility, and 4) increased ERK2 phosphorylation. These arrhythmias ceased 
after blockade of phosphohydrolysis of AMP to ADOby CD73, MEK/ERK pathway 
or A1AR. Exposure to exogenous INO also caused atrial ectopy associated with AVB 
and ERK2 phosphorylation which were prevented by A1AR or A2AAR antagonists or 
MEK/ERK inhibitor. Inhibition of the conversion by ADA of ADO to INO increased 
myocardial ADO and decreased INO as expected, but slightly augmented heart rate 
variability without provoking AVB. Thus, during cardiogenesis, disturbances of 
nucleosides metabolism and transport, can lead to interstitial accumulation of ADO 
and INO and provoke arrhythmias through A1AR and A2AAR stimulation and ERK2 
activation in an autocrine/paracrine manner.
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Intermittent hypoxia (IH), one of the major components of Obstructive Sleep Apnea 
Syndrome (OSAS), is at the origin of oxidative stress responsible for cardiovascular 
alterations. We have previously demonstrated that Hypoxia-Inducible Factor (HIF-1α) 
and one of its target genes Endothelin-1 (ET-1), a potent vasoactive peptide secreted 
by endothelial cells, are key players in these alterations. Moreover, HIF-1α activity is 
increased by oxidative stress and redox signaling pathways have been linked to changes 
in zinc homeostasis. Indeed, redox signaling leads to a zinc release from zinc-binding 
domains of proteins resulting in functional changes, a phenomenon called “zinc redox 
switch”. This discovery led to the development of the unique concept that, in addition to 
serving a structural function in proteins, zinc ions were likely to play a dynamic signaling 
regulatory role. Therefore, we postulated that perturbations of zinc homeostasis may 
modulate HIF-1α activity and ET-1 secretion, thereby leading to cardiovascular alterations.
In this study we tested whether changes in intracellular zinc content could 
modulate ET-1 secretion by human microvascular endothelial cells (HMVECs) through 
HIF-1α. Moreover, we investigated the role of zinc in endothelial cell migration using 
a wound-healing assay.
Using the ionophore zinc pyrithione we have observed that both ET-1 secretion 
and cell motility of HMVECs were downregulated by increases in intracellular zinc 
concentration (fi gure). On the other hand, zinc chelation by TPEN activated ET-1 
release and endothelial wound healing. We demonstrated that zinc pyrithione inhibited 
and TPEN activated HIF-1α relocation to the nucleus. Using siRNA directed against 
HIF-1α, we confi rmed that HIF-1α was the mediator of zinc-dependent ET-1 secretion 
and HMVEC migration. These data uncover a novel regulatory role of zinc potentially 















































































Figure – Abstract 318 – Role of zinc on HMVEC motility and ET-1 secretion.
